NEW YORK (Legal Newsline) — A shareholder has filed a class action lawsuit against a therapeutics business, alleging violation of federal law.
Yanbing Min filed a complaint, individually and on behalf of all others similarly situated, Feb. 6 in U.S. District Court for the Southern District of
Aratana Therapeutics Inc., Steven St. Peter and Craig A. Tooman,
alleging they issued inaccurate statements regarding the company's business and operation.
According to the complaint, Min sustained monetary damages from purchasing Aratana securities at artificially inflated prices. The plaintiff alleges the defendants made false statements and representations to the public in order to artificially inflate the securities prices.
Min seeks trial by jury, pay damages, interest, court costs, and all further relief the court grants. He is represented by attorneys Jeremy A. Lieberman, J. Alexander Hood II and Hui M. Chang of Pomerantz LLP in New York.
U.S. District Court for the Southern District of New York Case number 1:17-cv-00880-PAE